Athersys (NASDAQ:ATHX) Now Covered by StockNews.com
StockNews.com started coverage on shares of Athersys (NASDAQ:ATHX – Free Report) in a report published on Saturday morning. The firm issued a hold rating on the biopharmaceutical company’s stock. Athersys Stock Performance The company has a market cap of $833,000.00, a PE ratio of 0.00 and a beta of -0.90. Athersys has a 12-month low […]
StockNews.com started coverage on shares of Athersys (NASDAQ:ATHX – Free Report) in a report published on Saturday morning. The firm issued a hold rating on the biopharmaceutical company’s stock. Athersys Stock Performance The company has a market cap of $833,000.00, a PE ratio of 0.00 and a beta of -0.90. Athersys has a 12-month low […]
